Переход к основному содержанию
Підтримка для батьків від ЮНІСЕФ Україна
  • Дізнатись більше
 Европа и Центральная Азия Европа и Центральная Азия
  • English
  • русский

Global Links

  • Назад к ЮНИСЕФ
  • Высокий контраст
 Европа и Центральная Азия Европа и Центральная Азия
    • Узнать о ЮНИСЕФ
      • О нас
      • Наш мандат
      • Региональный директор
      • Положение детей в регионе
      • Где мы работаем
      • Портал для родителей
      • Наши голоса: Молодёжь региона
      • Послы ЮНИСЕФ в Европе и Центральной Азии
      • Наши партнеры
  • Пресс-центр
Поддержать

Main navigation

  • Что мы делаем
  • Исследования и отчеты
  • Истории из региона
  • Действуйте
Search area has closed test
Зона поиска открыта
ПОИСКЗакрыть

Поиск ЮНИСЕФ

  • Доступно на:
  • English
  • русский
  • Українська
  • Polish
  • Slovak
  • Hungarian
  • Czech
  • Блог (2)
  • (-) Заявление (3)
  • (-) Новостные заметки (1)
  • Отчет (1)
  • Пресс-релиз (15)
  • Статья (8)
  • Страница (3)
  • COVAX (4)
  • COVID-19 (9)
  • (-) Вакцины (3)
  • Вооружённый конфликт (1)
  • Грудное вскармливание (1)
  • Гуманитарный кризис и реагирование (1)
  • Здравоохранение (3)
  • Иммунизация (6)
  • Охрана материнского здоровья (1)
  • Равноправие (1)
  • (-) Учителя (1)
  • (-) Региональный офис ЮНИСЕФ по странам Европы и Центральной Азии (2)
  • Региональный офис ЮНИСЕФ по странам Европы и Центральной Азии (1)
  • (-) глобальной (2)
Statement
26 Апрель 2021
Celebrating the past, present and future benefits of vaccines
https://www.unicef.org/eca/press-releases/celebrating-past-present-and-future-benefits-vaccines
Copenhagen, Geneva, Brussels, 26 April 2021 - This past, difficult year of the COVID-19 pandemic has made clear how vulnerable we all are to a deadly new disease, when we don’t have the right vaccines or medical technologies we normally use to fight back. Long before COVID-19, one crucial tool – simply called “routine immunization” – was already saving millions of lives and preventing debilitating sickness, particularly among children. Routine immunization protects not only the person vaccinated, but also others in their communities. It helps pave the way to universal health coverage and Goal 3 of the Sustainable Development Goals – ensuring healthy lives and promoting well-being for all at all ages. The roll-out of COVID-19 vaccination at an ever-increasing speed across the WHO European Region, just a year after the start of the pandemic, is an impressive achievement. The European Union, WHO, UNICEF, all national governments and other partners have worked side by side in this response. Thanks to the global COVAX allocation mechanism and Team Europe’s effort some countries in the region that could not have competed on the global vaccine market on their own, are seeing vaccines being rolled-out. The European Union, WHO and UNICEF are now working with private and public sectors to overcome supply and capacity challenges and enable faster delivery. The uneven roll-out of COVID-19 vaccination to date highlights another truth: Inequitable access to health technologies between and within countries hurts us all. The virus and its impact on interlinked economies and societies know no borders. No country is safe until all countries are safe. While COVID-19 vaccination must continue at a faster and more equitable pace, it must not come at the cost of neglecting routine immunization. Any dip in routine coverage caused by the pandemic in 2020 or 2021 will pave the way for future outbreaks and jeopardize decades of progress.   In 2019, the European Region continued its record-breaking trend in routine vaccination coverage rates against measles and other vaccine preventable diseases. While 2020 saw an exceptionally low rate of reported measles cases, the pandemic has challenged national immunization programmes to keep up and catch up on routine shots. We must keep measles and other preventable diseases at bay by maintaining high routine vaccination coverage rates in every community, even during the pandemic. This year, more than ever, we call on everyone to do their part by choosing health information sources carefully, getting all routine vaccinations in due time and accepting COVID-19 vaccination for yourself and your loved ones when your turn comes. Talk to your children and others about vaccination, so they also come to see that it is not just an injection, but an investment in a healthier future and a safer world. A girl is getting her routine vaccination in Armenia. UNICEF Armenia/2021/Margaryan
Statement
15 Декабрь 2020
Teachers should be prioritized for vaccination against COVID-19
https://www.unicef.org/eca/press-releases/teachers-should-be-prioritized-vaccination-against-covid-19
NEW YORK, 15 December 2020 – “The COVID-19 pandemic has wreaked havoc on children’s education around the globe. Vaccinating teachers is a critical step towards putting it back on track.  “At their peak in late April 2020, nationwide school closures disrupted the learning of almost 90 per cent of students worldwide. While that number has dropped…
Statement
04 Декабрь 2020
As the COVID-19 pandemic begins to enter a new phase, UNICEF reminds the world that ‘the light at the end of the tunnel needs to shine for all’
https://www.unicef.org/eca/press-releases/covid-19-pandemic-begins-enter-new-phase-unicef-reminds-world-light-end-tunnel-needs
NEW YORK, 4 December 2020 – “COVID-19 is the first truly global crisis we have seen in our lifetimes. No matter where we live, the pandemic affects every one of us. Children have been seriously impacted. However, with more news about promising vaccines, and as we begin to imagine a day when COVID-19 is behind us, our guiding principle must be that the light at the end of the tunnel needs to shine for all. “This is why UNICEF has enthusiastically joined the Advance Market Commitment of the COVAX Facility to allow low- and lower-middle income countries access to COVID-19 vaccines. It is the best way to make sure that, as vaccines become available, no country is pushed to the back of the line. This would not only be fundamentally unfair, it would be unwise. The whole world will remain vulnerable to the virus until countries with the weakest health systems are protected from it as well. “In order for the COVAX Facility to work and guarantee equitable and affordable access to low- and lower-middle income countries, we need a global commitment to support and capitalize it, but also to finance the delivery of vaccines and associated supplies such as syringes and safety boxes. Governments must work together to ensure that COVID-19 vaccines are affordable and accessible to all countries. High-income countries should invest financially in the Advance Market Commitment and in UNICEF’s COVID-19 vaccine delivery efforts. All countries should take a strong stand against export controls on – and unnecessary stockpiling of – commodities for the COVID-19 response.  “UNICEF is also leveraging our unique strengths in community engagement and vaccine supply to make sure that countries participating in the COVAX Facility have safe, fast and equitable access to the vaccine. This is an enormous undertaking and many challenges still lay ahead.  As the largest vaccine buyer in the world,  procuring more than 2 billion doses  annually for routine immunization and outbreak response on behalf of nearly 100 countries, UNICEF is c oordinating and supporting  the procurement,  international freight , and in-country distribution of COVID-19 vaccines for the COVAX Facility. “Together with WHO, PAHO, GAVI and other partners at the global and regional levels, UNICEF is also working to support countries to ‘ready’ their immunization programmes for this historic roll-out. This includes assessing capacity and helping countries to strengthen their cold and supply chains so that they have adequate infrastructure to transport and store the vaccines for delivery to the frontlines. “However, the existence of a safe and effective COVID-19 vaccine alone will not end the pandemic. We need a diverse set of tools to help slow the spread of COVID-19, including diagnostics and treatments, as well as a continuance of preventive measures such as hand washing, physical distancing and mask wearing. UNICEF is providing governments with access to personal protective equipment, validated testing approaches, and proven treatments. In addition, UNICEF continues to work with multilateral partners to support governments with infection prevention control, water, sanitation and hygiene supplies, physical distancing, surveillance, contact tracing, case identification and community referral systems to stem the pandemic. “Lastly, we continue to help countries ensure the continuity of key essential services for women, children and young people – especially the most vulnerable. COVID-19 related disruptions have had a heavy impact on children: on their safety, their well-being, their future. Even as the fight against the disease enters into a hopeful new phase, we must not forget the work ahead of us to respond, recover and reimagine a better world for children.” ### Download photos  and broll here . For more information about COVID-19, visit  www.unicef.org/coronavirus . Find out more about UNICEF’s work on the COVID-19 vaccines  here , or about UNICEF’s work on immunization  here . About the Reimagine Campaign  In response to the COVID-19 pandemic, UNICEF has launched Reimagine — an urgent appeal to governments, the public, donors and the private sector to support UNICEF’s efforts to respond, recover and reimagine a world currently besieged by COVID-19. Together, we can prevent this pandemic from becoming a lasting crisis for children—especially the most vulnerable—and Reimagine a fairer world for every child. Join us:  https://www.unicef.org/coronavirus/covid-19/donate
News note
16 Июнь 2021
UNICEF signs supply agreement for Sputnik V COVID-19 vaccine
https://www.unicef.org/eca/press-releases/unicef-signs-supply-agreement-sputnik-v-covid-19-vaccine
NEW YORK/COPENHAGEN, 27 May 2021 -  UNICEF and Human Vaccine (Limited Liability Company), a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF), today announced a long-term agreement (LTA) for the supply of the Sputnik V COVID-19 vaccine. This is the fourth long-term supply agreement UNICEF has signed with a COVID-19 vaccine manufacturer. So far this year, UNICEF has signed such agreements with the Serum Institute of India, Pfizer and AstraZeneca. Procurement by UNICEF under this agreement is conditional on the product achieving an Emergency Use Listing from WHO, to confirm the quality, safety and efficacy of the vaccine.  In addition, an Advance Purchase Agreement (APA) with Gavi, the Vaccine Alliance, will also be needed for procurement to begin on behalf of the COVAX Facility. Should the COVAX Facility decide to enter into an advance purchase agreement for the supply of the Sputnik V vaccine, UNICEF will be ready to deliver as soon as regulatory milestones have been met. At this point, UNICEF through this LTA, stands ready to access up to 220 million doses of the vaccine available for supply in 2021, to meet country demand.  The Sputnik V vaccine consists of two different components of the vaccine to be administered 21 days apart. An exact delivery schedule will be determined in collaboration with the manufacturer. UNICEF’s priority is to make sure that all countries have safe, fast and equitable access to COVID-19 vaccine and to help them prepare for the rollout of immunization.  The best way to bring the pandemic under control is to ensure that safe and effective vaccines are made available as widely as possible and as quickly as possible, reducing inequity by ensuring that no country or territory is left behind due to its economic status. On 24 February 2021, COVID-19 vaccine vials are produced for the COVAX facility at a manufacturer in Pune, a city located in the western Indian state of Maharashtra. UNICEF/UN0421679?Singh

Footer

Главная
  • Что мы делаем
  • Положение детей в регионе Европы и Центральной Азии
  • Где мы работаем
Исследования и отчеты
  • Публикации
  • Наши партнеры
  • Послы ЮНИСЕФ в Европе и Центральной Азии
Поддержать

Social - ru

Footer Secondary

  • Наши контакты
  • Условия пользования